← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2013Last known activity
Mar 16, 2020
Timeline
2000s
- Jun 1, 2008
Stem Cells Arabia— Founded
Drugs by trial phase (3 distinct, 12 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Arthritis
- Arthritis, Rheumatoid
- Autoimmune Diseases
- Azoospermia
- Bulbar Palsy, Progressive
- Cerebral Palsy
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Endocrine System Diseases
- Glucose Metabolism Disorders
- Immune System Diseases
- Infertility
- Infertility, Male
- Menopause, Premature
- Metabolic Diseases
- Motor Neuron Disease
- Multiple Sclerosis
- Muscular Atrophy
- Muscular Atrophy, Spinal
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Optic Nerve Diseases
- Osteoarthritis
- Osteoarthritis, Hip
- Osteoarthritis, Knee
- Peripheral Nervous System Diseases
- Premature Birth
- Primary Ovarian Insufficiency
- Retinitis
- Retinitis Pigmentosa
- Sclerosis
- Spinal Cord Injuries
- Wounds and Injuries
Recent trials (14)
- NCT04313322Lead sponsorPhase 1Mar 16, 2020
- NCT04313322Reponsible party - principal investigatorPhase 1Mar 16, 2020
- NCT03067870Lead sponsorPhase 1Nov 1, 2016
- NCT03078621Lead sponsorPhase 1/Phase 2Sep 1, 2016
- NCT03067857Lead sponsorPhase 1/Phase 2Sep 1, 2016
- NCT03069170Lead sponsorPhase 1/Phase 2Jul 1, 2016
- NCT02687672Lead sponsorPhase 1/Phase 2Jan 1, 2016
- NCT03067831Lead sponsorPhase 1/Phase 2Sep 1, 2015
- NCT03069209Lead sponsorPhase 1/Phase 2Jan 1, 2015
- NCT02709876Lead sponsorPhase 1/Phase 2Apr 1, 2014
- NCT02644759Lead sponsorPhase 1/Phase 2Feb 1, 2014
- NCT02641769Lead sponsorPhase 1/Phase 2Jan 1, 2014
- NCT02641769Overall official - principal investigatorPhase 1/Phase 2Jan 1, 2014
- NCT02638714Lead sponsorPhase 1/Phase 2Apr 1, 2013
Details
- Founded
- Amman, JO Jun 1, 2008
- Last known activity
- Mar 16, 2020